Search Results

You searched for : empagliflozin

	CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure. ... May 20
	US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Latest Pharma News Update... Aug 23
	Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets Empagliflozin and Metformin Hydrochloride Extended-Release (ER) Tablets, are indicated as an adjunct to diet and exercise, to improve glycemic control in adults with type ... Jan 07
	Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial ... Nov 19
	Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets Empagliflozin and Linagliptin tablets, have an estimated market size of US$ 244 million for twelve months ending June 2020... Aug 27
	Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets Alembic receives USFDA approval for their erectile dysfunction drug ... Aug 05
	USFDA gives tentative nod to Zydus for Empagliflozin tablets The medication is used to improve blood sugar control in adults with Type 2 diabetes mellitus, along with diet and exercise.... Apr 13
	Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors Post-hoc analysis of the EMPA-REG OUTCOMEÂ® trial in adults with type 2 diabetes and established cardiovascular disease examined the cardiovascular benefits of empagliflozin ... Sep 20
8 Matching result(s) found!

-Advertisements-

Trending Now
	Navigating Legal Waters: Covishield's Side Effects Prompt Legal Battle from Parents May 02, 2024
	Mumps Resurgence in India: Understanding the Recent Outbreak and Prevention StrategiesMay 02, 2024
	Genomic Insights Unveiled: Illumina and Garvan Institute Collaborate to Map Disease FingerprintsMay 02, 2024
	10 key reasons why social media presence is crucial in healthcareApril 30, 2024
	Shocking Research Expose the Link Between Traffic Noise and Cardiovascular HealthApril 30, 2024
	How Are We Awaken After Anaesthesia: Study Reveals Reveals Brain's Protective MechanismApril 30, 2024
	Transformative Parenting Guide "Awakening Parenthood Vol-1" by Rommal Surana Debuts to AcclaimApril 29, 2024
	Sleep Quality and Its Influence on Chronic Kidney DiseaseApril 29, 2024
	Medulance is Official Emergency Services Partner of Delhi Capitals for a second time in IPL 2024April 29, 2024
	CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal VaccineApril 29, 2024
	Moving Towards Better Mental Health: Know The Impact of Low-intensity Workout For Your Mental Well-being April 29, 2024
	Exploring Mortality Risks for Lesbian and Bisexual Women: Key Findings from a Comprehensive Research EffortApril 29, 2024
	Implications of Alcohol Intake During Pregnancy on Fetal Development: New Study Reveals Subtle ChangesApril 29, 2024
	Indian Air Force's Night Vision Rescue: Soldier’s Life Saved in High-Stakes AirliftApril 29, 2024
	Now You Can Also Buy Insurance For Your Parents Aged Above 65 years: IRDAI Lifts Age Cap for Health Insurance Expanding Healthcare AccessApril 29, 2024
	Ensuring Infection Control: Central Government Hospitals Implement New Safety MeasuresApril 29, 2024
	9th Edition of the India Health and Wellness Awards 2024 Celebrate Excellence in Healthcare, Innovations in Health and Patient Centric Approach RecognisedApril 27, 2024
	Dish TV Revolutionizes Entertainment with ‘Dish TV Smart+’ Services, Offering TV and OTT on Any Screen, AnywhereApril 26, 2024
	Arohan Financial Services Recognized Among India's Best Workplaces in BFSI 2024April 26, 2024
	Why Podcasts Are the Next Big Thing in Healthcare Advertising in IndiaApril 26, 2024

Search Results

CDSCO has approved Boehringer Ingelheim's Jardiance for the treatment of heart failure.

US FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction

Lupin Receives Tentative Approval for Empagliflozin and Metformin Hydrochloride ER Tablets

Empagliflozin reduced the risk of first plus recurrent cardiovascular events in adults with type 2 diabetes and established cardiovascular disease in new analysis from the EMPA-REG OUTCOME trial

Alembic Pharma receives USFDA tentative approval for Empagliflozin and Linagliptin tablets

Alembic Pharmaceuticals receives USFDA approval for Vardenafil Hydrochloride tablets

USFDA gives tentative nod to Zydus for Empagliflozin tablets

Consistent cardiovascular benefits shown with empagliflozin treatment regardless of the number of controlled cardiovascular risk factors

Trending Now